In this episode of BioTalk from BioTechniques, Gal Almogy, a post-doc at ETH Zürich explains how increasing the accuracy of the Tet system might lead to effective gene therapy.
Gal Almogy, together with Gary Nolan associate professor at Stanford University, published a research report in the January 2009 issue of BioTechniques describing their improvements to the Tet system.
Almogy also discusses his career goals in the synthetic biology field and his desire to help students and post-docs navigate the academic job market.
Antibody Validation | BenchTalk November 2013
Epigenetics Sept 2013 V2
The Translation Research Emphasis | BenchTalk, Episode 14
Behind the Scenes of GE's Cell Imaging Contest | BenchTalk, Episode 13
The Rise in Droplet PCR | BenchTalk, Episode 12
AGBT13 Round-Up: Advances in Genome Biology and Technology | BenchTalk, Episode 11 New York, NY